- March 12, 2024
Five From Yale School of Medicine Elected to Association of American Physicians
- March 06, 2024
Study Probes Blood Biomarker for Early-stage Alzheimer's Disease
- February 28, 2024Source: YaleNews
Risk of Hospital Readmission After Surgery Is High for Older Americans
- January 31, 2024Source: Yale Medicine
How to Stay Connected with a Loved One With Alzheimer’s Disease
- November 20, 2023
Computational Tool Advances Understanding of COVID-19 and Alzheimer’s Disease
- November 20, 2023
Molecules Within Olive Oil May Potentially Prevent or Treat Alzheimer's Disease
Yale Alzheimer’s Disease Research Center
Our Center
Alzheimer’s disease is the 6th leading cause of death in the United States. An estimated 5.7 million Americans of all ages have Alzheimer's disease, with more than 77,000 in the state of Connecticut alone.
The Yale Alzheimer's Disease Research Center is funded by the National Institutes of Health, National Institute on Aging (NIA) .
The Yale Alzheimer’s Disease Research Center’s goal is to advance the understanding and treatment of Alzheimer’s disease through research, clinical trials, and career development for Alzheimer researchers, community outreach and education. Emphasis will be the translational development of research findings into therapeutic benefit. The Center will share data and research results with other researchers who are also studying this disease.
The Center will connect with the communities of Connecticut to educate families burdened with AD, both with regard to hopeful directions of research and to resources for clinical care and emotional support.
Contact Us
295 Congress Ave, PO Box 9812, BCMM 436D, New Haven CT 06519